Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/31/1996WO1996033691A2 Use of cgrp for treating hair loss
10/31/1996WO1996027663A3 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
10/31/1996WO1996021011A3 PEPTIDES SPECIFIC FOR THE FIRST Crk-SH3 DOMAIN
10/31/1996WO1991000046A3 Method and apparatus for preparing fibrinogen adhesive from whole blood
10/31/1996DE19516673A1 Vaccines against human, pref. mucin expressing, tumours
10/31/1996CA2761116A1 Human antibodies derived from immunized xenomice
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2219486A1 Human antibodies derived from immunized xenomice
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2219263A1 Antagonists of lhrh
10/31/1996CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996CA2219214A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/31/1996CA2218880A1 Process for preparing anti-obesity protein
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996CA2216532A1 Inhibitors of farnesyl-protein transferase
10/31/1996CA2215737A1 Lh-rh receptor antagonists
10/31/1996CA2214029A1 Single-vial formulations of dna/lipid complexes
10/31/1996CA2203435A1 N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
10/31/1996CA2194070A1 Novel polypeptides
10/31/1996CA2193354A1 Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
10/30/1996EP0739981A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/30/1996EP0739980A2 DNA encoding CD 19
10/30/1996EP0739904A1 Bispecific reagents for aids therapy
10/30/1996EP0739903A1 Carbamoylmethylurea derivative
10/30/1996EP0739633A2 Use of antithrombin III to increase placental blood flow
10/30/1996EP0739631A2 Laminar bone support for cartilage growth
10/30/1996EP0739415A1 Anti-hepatitis b poly- and oligonucleotides
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739354A1 Compositions and methods using unbound mpl receptor for stimulating platelet production
10/30/1996EP0739352A1 New composition of glycoprotein isoforms having follicle stimulating activity
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739212A1 Use of interleukin-12 to prevent graft versus host disease
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996EP0739207A1 Enteral formula with ribo-nucleotides
10/30/1996EP0739204A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
10/30/1996EP0592476B1 Use of interleukine 10 to produce drugs with a tumour-inhibiting action
10/30/1996EP0573576B1 Compositions for topical administration of pharmaceutically active agents
10/30/1996EP0527852B1 Method and compositions for treating injury
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996EP0487613B1 A megakaryocytopoietic factor
10/30/1996EP0479909B1 Bispecific reagents for aids therapy
10/30/1996CN1134707A Peptide and antithrombotic agent
10/30/1996CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134704A Drug binding protein
10/30/1996CN1134696A Substituted 5-ring heterocycles, their preparation and their use
10/30/1996CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
10/30/1996CN1134665A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound
10/30/1996CN1134460A HTFIIIA gent
10/30/1996CN1134270A Center dispense suture package
10/29/1996US5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
10/29/1996US5569768 Angiotensin II antagonists
10/29/1996US5569755 Antitumor agents
10/29/1996US5569744 A modified polypeptide; reduced risk for diabetes type ii, cardiovascular disorder and cancer; regulates fat tissues
10/29/1996US5569743 Anti-obesity proteins
10/29/1996US5569742 Centrally truncated NPY cyclic peptides
10/29/1996US5569741 Cyclic octapeptide neuromedin B receptor antagonists
10/29/1996US5569720 Water soluble; antitumor agents
10/29/1996US5569648 Administering insulin-like growth factor
10/29/1996US5569647 Angiopeptin cyclopeptide compounds
10/29/1996US5569646 Treatment of pneumonia; microbiocides, fungicides
10/29/1996US5569603 Parasiticide
10/29/1996US5569602 First immortalized Kaposi's sarcoma cell line
10/29/1996US5569462 Placing a population of therapeutic substance producing cells into cell receiving chamber of immunoisolation apparatus, implanting apparatus into patient, administering an immunomodulatory agent
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996US5569452 Pharmaceutical formulation having enhanced bile acid binding affinity
10/29/1996CA1338683C Fatty acid therapy and compositions
10/29/1996CA1338682C Biologically active undenatured whey protein concentrate as food supplement
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033416A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins
10/24/1996WO1996033414A2 Compounds and methods for diagnosis of leishmaniasis
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033280A1 An adenovirus helper-virus system
10/24/1996WO1996033277A2 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses
10/24/1996WO1996033275A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
10/24/1996WO1996033274A1 Helicobacter pylori cagi region
10/24/1996WO1996033273A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
10/24/1996WO1996033264A1 Purified and isolated sertoli cell aggregate
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996033218A1 Anti-haemorrhagic peptides
10/24/1996WO1996033217A1 Cell adhesion protein, immunosuppressive agent containing the same, and immunosuppressive agent containing cells induced thereby
10/24/1996WO1996033216A1 Truncated igf-i
10/24/1996WO1996033215A1 Novel protein and process for producing the same
10/24/1996WO1996033213A1 Method for preparing streptogramines
10/24/1996WO1996033212A1 Novel peptide derivatives
10/24/1996WO1996033211A1 Biologically active peptides and compositions, their use
10/24/1996WO1996033210A1 Amines exhibiting analgesic action, their preparation and use
10/24/1996WO1996033209A1 Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
10/24/1996WO1996033208A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy
10/24/1996WO1996033206A1 Conotoxin peptides
10/24/1996WO1996033204A1 Multiple administrations of anti-tnf antibody
10/24/1996WO1996033198A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/24/1996WO1996033184A1 Thf-containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033170A1 N-aroylamino acid amides as endothelin inhibitors
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
1 ... 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 ... 3163